Gary Oderda

Summary

Affiliation: University of Utah
Country: USA

Publications

  1. ncbi request reprint Opioid-related adverse drug events in surgical hospitalizations: impact on costs and length of stay
    Gary M Oderda
    Pharmacotherapy Outcomes Research Center, University of Utah Health Sciences Center, Salt Lake City, UT 84108, USA
    Ann Pharmacother 41:400-6. 2007
  2. ncbi request reprint Bringing liraglutide to market: a CER case study
    Gary Oderda
    Pharmacotherapy Outcomes Research Center, University of Utah, College of Pharmacy, 421 Wakara Way, Salt Lake City, UT 84108, USA
    J Manag Care Pharm 18:S12-8. 2012
  3. pmc Systematic review on quality control for drug management programs: is quality reported in the literature?
    Anke Peggy Holtorf
    Department of Pharmacotherapy, The University of Utah, Millcreek Outcomes Group, Salt Lake City, UT, USA
    BMC Health Serv Res 9:38. 2009
  4. ncbi request reprint Characterization of therapy and costs for patients with uterine fibroids in Utah Medicaid
    Gary Oderda
    Department of Pharmacotherapy, Pharmacotherapy Outcomes Research Center, University of Utah College of Pharmacy, 421 Wakara Way, Suite 208, Salt Lake City, UT 84108, USA
    Arch Gynecol Obstet 276:211-8. 2007
  5. ncbi request reprint Increasing pneumococcal vaccination rates among adults with cystic fibrosis
    David C Young
    Intermountain Cystic Fibrosis Adult Center, Salt Lake City, UT, USA
    Am J Health Syst Pharm 61:1490-3. 2004
  6. doi request reprint Challenges in the management of acute postsurgical pain
    Gary Oderda
    Pharmacotherapy Outcomes Research Center, University of Utah College of Pharmacy, Salt Lake City, Utah 84112, USA
    Pharmacotherapy 32:6S-11S. 2012
  7. ncbi request reprint Adherence and persistence with single-dosage form extended-release niacin/lovastatin compared with statins alone or in combination with extended-release niacin
    Joanne LaFleur
    Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, 84108, USA
    Ann Pharmacother 40:1274-9. 2006
  8. ncbi request reprint Gastrointestinal complications of over-the-counter nonsteroidal antiinflammatory drugs
    Joseph E Biskupiak
    Pharmacotherapy Outcomes Research Center, Department of Pharmacotherapy, University of Utah College of Pharmacy, 421 Wakara Way, Suite 208, Salt Lake City, UT 84108, USA
    J Pain Palliat Care Pharmacother 20:7-14. 2006
  9. ncbi request reprint Economic evaluations in pain management: principles and methods
    Carl V Asche
    Pharmacotherapy Outcomes Research Center, Department of Pharmacotherapy, University of Utah College of Pharmacy, 421 Wakara Way, Suite 208, Salt Lake City, UT 84108, USA
    J Pain Palliat Care Pharmacother 20:15-23. 2006
  10. ncbi request reprint Incidence and economic implications of heparin-induced thrombocytopenia in medical patients receiving prophylaxis for venous thromboembolism
    Freddy M Creekmore
    College of Pharmacy, University of Utah, Salt Lake City, Utah 84112
    Pharmacotherapy 26:1438-45. 2006

Detail Information

Publications24

  1. ncbi request reprint Opioid-related adverse drug events in surgical hospitalizations: impact on costs and length of stay
    Gary M Oderda
    Pharmacotherapy Outcomes Research Center, University of Utah Health Sciences Center, Salt Lake City, UT 84108, USA
    Ann Pharmacother 41:400-6. 2007
    ..Opioid analgesics remain a mainstay in the treatment of pain associated with surgical procedures. Such use is associated with adverse drug events (ADEs)...
  2. ncbi request reprint Bringing liraglutide to market: a CER case study
    Gary Oderda
    Pharmacotherapy Outcomes Research Center, University of Utah, College of Pharmacy, 421 Wakara Way, Salt Lake City, UT 84108, USA
    J Manag Care Pharm 18:S12-8. 2012
    ..But few examples exist to show how CER can be used effectively and whether the data can make a difference...
  3. pmc Systematic review on quality control for drug management programs: is quality reported in the literature?
    Anke Peggy Holtorf
    Department of Pharmacotherapy, The University of Utah, Millcreek Outcomes Group, Salt Lake City, UT, USA
    BMC Health Serv Res 9:38. 2009
    ..The objective of this study was to evaluate how the impact of drug management programs is reported in the literature and to identify potentially existing quality standards...
  4. ncbi request reprint Characterization of therapy and costs for patients with uterine fibroids in Utah Medicaid
    Gary Oderda
    Department of Pharmacotherapy, Pharmacotherapy Outcomes Research Center, University of Utah College of Pharmacy, 421 Wakara Way, Suite 208, Salt Lake City, UT 84108, USA
    Arch Gynecol Obstet 276:211-8. 2007
    ..To determine in an eligible Utah Medicaid population (1) medical and drug costs associated with treating uterine fibroids (UFs) and (2) the cost and incidence of hysterectomy complications...
  5. ncbi request reprint Increasing pneumococcal vaccination rates among adults with cystic fibrosis
    David C Young
    Intermountain Cystic Fibrosis Adult Center, Salt Lake City, UT, USA
    Am J Health Syst Pharm 61:1490-3. 2004
  6. doi request reprint Challenges in the management of acute postsurgical pain
    Gary Oderda
    Pharmacotherapy Outcomes Research Center, University of Utah College of Pharmacy, Salt Lake City, Utah 84112, USA
    Pharmacotherapy 32:6S-11S. 2012
    ..Strategies to reduce the use of opioids after surgery are likely to result in positive outcomes by reducing the incidence of ORADEs and, as a result, reducing treatment costs associated with surgery and improving patient care...
  7. ncbi request reprint Adherence and persistence with single-dosage form extended-release niacin/lovastatin compared with statins alone or in combination with extended-release niacin
    Joanne LaFleur
    Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, 84108, USA
    Ann Pharmacother 40:1274-9. 2006
    ..A fixed-dose combination product, extended-release niacin/lovastatin (ERNL), has been shown to be beneficial in lipid management; however, little is known regarding patient behavior with ERNL therapy...
  8. ncbi request reprint Gastrointestinal complications of over-the-counter nonsteroidal antiinflammatory drugs
    Joseph E Biskupiak
    Pharmacotherapy Outcomes Research Center, Department of Pharmacotherapy, University of Utah College of Pharmacy, 421 Wakara Way, Suite 208, Salt Lake City, UT 84108, USA
    J Pain Palliat Care Pharmacother 20:7-14. 2006
    ....
  9. ncbi request reprint Economic evaluations in pain management: principles and methods
    Carl V Asche
    Pharmacotherapy Outcomes Research Center, Department of Pharmacotherapy, University of Utah College of Pharmacy, 421 Wakara Way, Suite 208, Salt Lake City, UT 84108, USA
    J Pain Palliat Care Pharmacother 20:15-23. 2006
    ....
  10. ncbi request reprint Incidence and economic implications of heparin-induced thrombocytopenia in medical patients receiving prophylaxis for venous thromboembolism
    Freddy M Creekmore
    College of Pharmacy, University of Utah, Salt Lake City, Utah 84112
    Pharmacotherapy 26:1438-45. 2006
    ....
  11. ncbi request reprint Prevalence of drug-related problems and cost-savings opportunities in medicaid high utilizers identified by a pharmacist-run drug regimen review center
    Joanne LaFleur
    Drug Regimen Review Center, Department of Pharmacotherapy, University of Utah College of Pharmacy, Salt Lake City, UT, USA
    J Manag Care Pharm 12:677-85. 2006
    ..The DUR program was designed to suggest ways that high-utilizing patients could decrease their total number of medications to 7 or fewer prior to imposition of the 7-medication limit at some time in the future...
  12. ncbi request reprint Opioid expenditures and utilization in the Medicaid system
    Diana I Brixner
    Department of Pharmacotheraphy, University of Utah, Salt Lake City, UT 84112, USA
    J Pain Palliat Care Pharmacother 20:5-13. 2006
    ..By 2003, opioids represented about a four percent share of all Medicaid prescription drugs. Variations among the states in per-enrollee spending on opioids are substantial. The appropriateness of these variations is unknown...
  13. ncbi request reprint Cost of opioid-related adverse drug events in surgical patients
    Gary M Oderda
    University of Utah College of Pharmacy and School of Medicine, Salt Lake City, UT, USA
    J Pain Symptom Manage 25:276-83. 2003
    ..The estimated log cost difference of 16%, if applied to the median cost patient in the non-ADE group, averaged US$ 840. Opioid-related ADEs are common in hospitalized patients and increase LOS and total hospital costs...
  14. ncbi request reprint Naturalistic impact of second-generation antipsychotics on weight gain
    Diana I Brixner
    Executive Pharmacotherapy Outcomes Research Center, University of Utah, Salt Lake City, UT 84108, USA
    Ann Pharmacother 40:626-32. 2006
    ..Body mass index (BMI) has been studied in clinical trials with limited comparison between drugs...
  15. ncbi request reprint Documentation of chemotherapy infusion preparation costs in academic- and community-based oncology practices
    Diana I Brixner
    University of Utah Pharmacotherapy Outcomes Research Center, Salt Lake City, Utah, 84108, USA
    J Natl Compr Canc Netw 4:197-208. 2006
    ..These data provide scientific support for the consideration of appropriate reimbursement for chemotherapy services provided by pharmacists to Medicare beneficiaries...
  16. ncbi request reprint The economic impact of GERD and PUD: examination of direct and indirect costs using a large integrated employer claims database
    Vijay N Joish
    Pharmacotherapy Outcomes Research Center, University of Utah College of Pharmacy, Salt Lake City, UT, USA
    Curr Med Res Opin 21:535-44. 2005
    ....
  17. ncbi request reprint The importance of perspective in pharmacoeconomic analyses
    Gary M Oderda
    College of Pharmacy, and Pain Research Center, University of Utah Health Sciences Center, Salt Lake City, USA
    J Pain Palliat Care Pharmacother 16:65-9. 2002
    ..The most common perspectives are those of providers, payers, patients, and society. The societal perspective is broadest and is usually preferred...
  18. ncbi request reprint Cost-utility analysis and quality adjusted life years
    Vijay N Joish
    College of Pharmacy, Pharmacotherapy Outcomes Research Center, University of Utah Health Sciences Center, Salt Lake City, UT 84108, USA
    J Pain Palliat Care Pharmacother 19:57-61. 2005
    ..This article provides an overview of cost utility analysis and quality adjusted life years, a commonly used effectiveness measure in CUA when comparing two or more treatments or interventions...
  19. ncbi request reprint Cost-of-illness studies
    Gary M Oderda
    College of Pharmacy, Pain Management Outcomes and Pharmacoeconomics Research Center, University of Utah Health Sciences Center, USA
    J Pain Palliat Care Pharmacother 17:59-62. 2003
    ..Comparison of cost-of-illness studies from different countries is difficult because of differences in population, currency, the way health care is provided, and other social and political factors...
  20. ncbi request reprint Methods to measure patient compliance with medication regimens
    Joanne LaFleur
    Pharmacotherpay Outcomes Research Center, University of Utah, Salt Lake City, UT 84108, USA
    J Pain Palliat Care Pharmacother 18:81-7. 2004
    ..Objective methods include pill counting, electronic monitoring devices, and data reviews; these methods vary in cost and reliability...
  21. ncbi request reprint Outcomes research: what it is and what it isn't
    Gary M Oderda
    College of Pharmacy and Pain Research Center, University of Utah Health Sciences Center, USA
    J Pain Palliat Care Pharmacother 16:83-9. 2002
    ..To the contrary, outcomes research is a powerful tool, but like many others it has limitations and it is important to understand both what outcomes research is, and what it isn't...
  22. ncbi request reprint Providing diabetes education and care to underserved patients in a collaborative practice at a utah community health center
    Laura Shane-McWhorter
    Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, Utah 84112, USA
    Pharmacotherapy 25:96-109. 2005
    ..However, more patients who were provided care by the pharmacist CDE reached the American Diabetes Association A1C target goal of below 7%...
  23. ncbi request reprint Has the cost-effectiveness of Xolair (omalizumab) been underestimated?
    Carl V Asche
    J Allergy Clin Immunol 115:1095; author reply 1095-6. 2005
  24. ncbi request reprint Older and younger adults in pain management programs in the United States: differences and similarities
    Harriet M Wittink
    Department of Physical Therapy, University of Professional Education and Academy of Health Sciences Utrecht, Utrecht University, Utrecht, The Netherlands
    Pain Med 7:151-63. 2006
    ....